Home

Unfall Hingeben Meister chan carter 2010 nature reviews immunol 10 301 töten Engagieren Gleich

Antibody recycling by engineered pH-dependent antigen binding improves the  duration of antigen neutralization | Nature Biotechnology
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization | Nature Biotechnology

Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils:  Shifting the Balance | Immunology
Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance | Immunology

Frontiers | Mass Cytometry Imaging for the Study of Human  Diseases—Applications and Data Analysis Strategies | Immunology
Frontiers | Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies | Immunology

Preferential Presentation of High-Affinity Immune Complexes in Germinal  Centers Can Explain How Passive Immunization Improves the Humoral Response  - ScienceDirect
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect

Preferential Presentation of High-Affinity Immune Complexes in Germinal  Centers Can Explain How Passive Immunization Improves the Humoral Response  - ScienceDirect
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in  Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular  Pharmacology
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology

Frontiers | Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated  Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry  of Fc Moieties | Chemistry
Frontiers | Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties | Chemistry

Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into  Long-Lived Plasma Cells | Immunology
Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells | Immunology

Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews  Immunology
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology

Lymph node choreography: B cells take the lead | Nature Immunology
Lymph node choreography: B cells take the lead | Nature Immunology

mRNA as novel technology for passive immunotherapy | SpringerLink
mRNA as novel technology for passive immunotherapy | SpringerLink

Tools to therapeutically harness the human antibody response | Nature  Reviews Immunology
Tools to therapeutically harness the human antibody response | Nature Reviews Immunology

Vaccine candidate discovery for the next generation of malaria vaccines -  Tuju - 2017 - Immunology - Wiley Online Library
Vaccine candidate discovery for the next generation of malaria vaccines - Tuju - 2017 - Immunology - Wiley Online Library

Frontiers | Modulation of Signaling Mediated by TSLP and IL-7 in  Inflammation, Autoimmune Diseases, and Cancer | Immunology
Frontiers | Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer | Immunology

Microfluidic single-cell technology in immunology and antibody screening -  ScienceDirect
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect

PDF) Techniques to Study Antigen-Specific B Cell Responses
PDF) Techniques to Study Antigen-Specific B Cell Responses

Figure 3 from Therapeutic antibodies for autoimmunity and inflammation |  Semantic Scholar
Figure 3 from Therapeutic antibodies for autoimmunity and inflammation | Semantic Scholar

Cancer systems immunology | eLife
Cancer systems immunology | eLife

mRNA as novel technology for passive immunotherapy | SpringerLink
mRNA as novel technology for passive immunotherapy | SpringerLink

Post‐transcriptional control of immune responses and its potential  application - Yoshinaga - 2019 - Clinical & Translational Immunology -  Wiley Online Library
Post‐transcriptional control of immune responses and its potential application - Yoshinaga - 2019 - Clinical & Translational Immunology - Wiley Online Library

Advances in targeting cell surface signalling molecules for immune  modulation | Nature Reviews Drug Discovery
Advances in targeting cell surface signalling molecules for immune modulation | Nature Reviews Drug Discovery

Antibody-dependent fragmentation is a newly identified mechanism of cell  killing in vivo | Scientific Reports
Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo | Scientific Reports

Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews  Immunology
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology

Alternative molecular formats and therapeutic applications for bispecific  antibodies - ScienceDirect
Alternative molecular formats and therapeutic applications for bispecific antibodies - ScienceDirect